BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND SRSF3, SRp20, SFRS3, 6428, ENSG00000112081, P84103
21 results:

  • 1. Impact of hospital volume on failure to rescue for complications requiring reoperation after elective colorectal surgery: multicentre propensity score-matched cohort study.
    Grönroos-Korhonen MT; Koskenvuo LE; Mentula PJ; Nykänen TP; Koskensalo SK; Leppäniemi AK; Sallinen VJ
    BJS Open; 2024 Mar; 8(2):. PubMed ID: 38597158
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. SCARB1-encoded circ _0029343 induces p73 splicing to promote growth and metastasis of hepatocellular carcinoma via miR-486-5p/srsf3 axis.
    Zhu S; Cao S; Che J; Zhao L; Su Z; Li D; Pei R; Xu L; Ding Y; Zhou W
    J Biochem Mol Toxicol; 2024 Feb; 38(2):e23646. PubMed ID: 38345168
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma.
    Webster NJG; Kumar D; Wu P
    Sci Rep; 2024 Jan; 14(1):2500. PubMed ID: 38291075
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic compensation response could exist in colorectal cancer: UPF3A upregulates the oncogenic homologue gene srsf3 expression corresponding to SRSF6 to promote colorectal cancer metastasis.
    Xu W; Ou W; Feng Y; Xu Q; Yang Y; Cui L; Du P
    J Gastroenterol Hepatol; 2023 Apr; 38(4):634-647. PubMed ID: 36807382
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Panomics reveals patient individuality as the major driver of colorectal cancer progression.
    Praus F; Künstner A; Sauer T; Kohl M; Kern K; Deichmann S; Végvári Á; Keck T; Busch H; Habermann JK; Gemoll T
    J Transl Med; 2023 Jan; 21(1):41. PubMed ID: 36691026
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. srsf3 and HNRNPH1 Regulate Radiation-Induced Alternative Splicing of Protein Arginine Methyltransferase 5 in Hepatocellular Carcinoma.
    Wen C; Tian Z; Li L; Chen T; Chen H; Dai J; Liang Z; Ma S; Liu X
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499164
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma.
    Kumar D; Das M; Oberg A; Sahoo D; Wu P; Sauceda C; Jih L; Ellies LG; Langiewicz MT; Sen S; Webster NJG
    Adv Sci (Weinh); 2022 Jul; 9(21):e2105120. PubMed ID: 35615981
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer.
    Hui B; Lu C; Wang J; Xu Y; Yang Y; Ji H; Li X; Xu L; Wang J; Tang W; Wang K; Gu Y
    J Cell Physiol; 2022 Jan; 237(1):911-933. PubMed ID: 34463962
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein srsf3.
    Chen D; Zhao Z; Chen L; Li Q; Zou J; Liu S
    Cell Death Dis; 2021 Jul; 12(8):722. PubMed ID: 34290239
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Proteomic Characterization of Proliferation Inhibition of Well-Differentiated Laryngeal Squamous Cell Carcinoma Cells Under Below-Background Radiation in a Deep Underground Environment.
    Liu J; Ma T; Gao M; Liu Y; Liu J; Wang S; Xie Y; Wen Q; Wang L; Cheng J; Liu S; Zou J; Wu J; Li W; Xie H
    Front Public Health; 2020; 8():584964. PubMed ID: 33194991
    [No Abstract]    [Full Text] [Related]  

  • 12. srsf3 Depletion Leads to an Increase in SF3B4 Expression in SNU-368 HCC Cells.
    Lee J; Seo G; Hur W; Yoon SK; Nam SW; Lee JH
    Anticancer Res; 2020 Apr; 40(4):2033-2042. PubMed ID: 32234894
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Alteration of splicing factors' expression during liver disease progression: impact on hepatocellular carcinoma outcome.
    Wang H; Lekbaby B; Fares N; Augustin J; Attout T; Schnuriger A; Cassard AM; Panasyuk G; Perlemuter G; Bieche I; Vacher S; Selves J; Péron JM; Bancel B; Merle P; Kremsdorf D; Hall J; Chemin I; Soussan P
    Hepatol Int; 2019 Jul; 13(4):454-467. PubMed ID: 31140152
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Splicing events in the control of genome integrity: role of SLU7 and truncated srsf3 proteins.
    Jiménez M; Urtasun R; Elizalde M; Azkona M; Latasa MU; Uriarte I; Arechederra M; Alignani D; Bárcena-Varela M; Álvarez-Sola G; Colyn L; Santamaría E; Sangro B; Rodriguez-Ortigosa C; Fernández-Barrena MG; Ávila MA; Berasain C
    Nucleic Acids Res; 2019 Apr; 47(7):3450-3466. PubMed ID: 30657957
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long-Read RNA Sequencing Identifies Alternative Splice Variants in Hepatocellular Carcinoma and Tumor-Specific Isoforms.
    Chen H; Gao F; He M; Ding XF; Wong AM; Sze SC; Yu AC; Sun T; Chan AW; Wang X; Wong N
    Hepatology; 2019 Sep; 70(3):1011-1025. PubMed ID: 30637779
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Proteomic Characterization of Transcription and Splicing Factors Associated with a Metastatic Phenotype in Colorectal cancer.
    Torres S; García-Palmero I; Marín-Vicente C; Bartolomé RA; Calviño E; Fernández-Aceñero MJ; Casal JI
    J Proteome Res; 2018 Jan; 17(1):252-264. PubMed ID: 29131639
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Risk of cancer in patients with heart failure who use digoxin: a 10-year follow-up study and cell-based verification.
    Chung MH; Wang YW; Chang YL; Huang SM; Lin WS
    Oncotarget; 2017 Jul; 8(27):44203-44216. PubMed ID: 28496002
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. An indel polymorphism within pre-miR3131 confers risk for hepatocellular carcinoma.
    Wang C; Li L; Yin Z; Zhang Q; Zhao H; Tao R; Wang S; Hu S; He Y; Wang D; Li C; Zhang S; Xu J; Jiang X; Zhu S; Gao Y
    Carcinogenesis; 2017 Feb; 38(2):168-176. PubMed ID: 28034876
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Deletion of serine/arginine-rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice.
    Sen S; Langiewicz M; Jumaa H; Webster NJ
    Hepatology; 2015 Jan; 61(1):171-83. PubMed ID: 25132062
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Splicing regulator SLU7 is essential for maintaining liver homeostasis.
    Elizalde M; Urtasun R; Azkona M; Latasa MU; Goñi S; García-Irigoyen O; Uriarte I; Segura V; Collantes M; Di Scala M; Lujambio A; Prieto J; Ávila MA; Berasain C
    J Clin Invest; 2014 Jul; 124(7):2909-20. PubMed ID: 24865429
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.